Unlabelled: A patient with antisynthetase syndrome with pulmonary and muscular involvement was treated with immunosuppressive agents without corticosteroids. Rituximab was added to mycophenolate mofetil therapy with improvement in lung functional and imaging findings and normalization of creatine kinase levels.
Learning Points: Antisynthetase syndrome associated with interstitial lung disease (ILD) and myopathy can be successfully treated without corticosteroids.A combination of several immunosuppressive agents can be a therapeutic alternative in case of refractory ILD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426970 | PMC |
| http://dx.doi.org/10.12890/2022_003324 | DOI Listing |
Publication Analysis
Top Keywords
mycophenolate mofetil
8
antisynthetase syndrome
8
immunosuppressive agents
8
case anti-synthetase
4
anti-synthetase syndrome
4
syndrome treated
4
treated mycophenolate
4
mofetil rituximab
4
rituximab corticosteroids
4
corticosteroids unlabelled
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!